Announced Tue, 16 Jun · 14:04 IST
AstraZeneca Pharma India appoints Praveen K Mittal as Director - Corporate Affairs
Management Changes View source PDF
ASTRAZEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.5%1-day move
₹8400.00
prior close
₹8442.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.0+0.0+0.5+0.9+1.5+1.4+0.7+2.1+1.0+0.5-3.0-3.1——
Up moveDown movePending
AI summary
AstraZeneca Pharma India has appointed Mr. Praveen K Mittal as Director - Corporate Affairs, effective July 6, 2026, on a full-time basis. The Board approved the role based on the Nomination and Remuneration Committee's recommendation. Mittal has nearly 30 years of experience in corporate affairs, public policy, and government relations, currently leading EPCMD and previously heading FICCI's healthcare division for over 18 years.
Likely market impact
Strengthens senior leadership in government relations and policy advocacy, areas critical for pharma. Likely neutral to mildly positive for the stock.